Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 923 of 923 entries
View as:

Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05896865 Org: User:
Start: 03/16/23 End: 03/16/30 Due: 03/16/31

The Long-term Clinical Outcomes and Patterns of Transfusion in PCI Patients: Retrospective Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT03776266 Org: User:
Start: 10/05/18 End: 11/30/18 Due: 11/30/19

GENOSS Coronary Stent Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT05444452 Org: User:
Start: 04/24/22 End: 06/30/27 Due: 06/30/28

Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane

Phase: N/A Priority: Normal
NCT ID: NCT01503606 Org: User:
Start: 10/31/11 End: 12/31/21 Due: 12/31/22

Therapeutic Effects of Constraint-Induced Movement Therapy on Young Children With Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT03858335 Org: User:
Start: 09/14/15 End: 09/28/19 Due: 09/28/20

Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane

Phase: N/A Priority: Normal
NCT ID: NCT01985490 Org: User:
Start: 11/30/13 End: 05/31/15 Due: 05/31/16

Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy

Phase: N/A Priority: Normal
NCT ID: NCT00803517 Org: User:
Start: 03/31/08 End: 10/31/08 Due: 10/31/09

Clinical Predictors of Apnea-hypopnea During Propofol Sedation

Phase: N/A Priority: Normal
NCT ID: NCT01871259 Org: User:
Start: 11/30/08 End: 11/30/09 Due: 11/30/10

The Current Status and Clinical Outcomes of Patients With Cardiogenic Shock II

Phase: N/A Priority: Normal
NCT ID: NCT04143893 Org: User:
Start: 05/30/19 End: 12/31/24 Due: 12/31/25

The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT06350487 Org: User:
Start: 05/01/24 End: 06/30/26 Due: 06/30/27

A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02227953 Org: User:
Start: 08/31/14 End: 12/31/14 Due: 12/31/15

Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03166904 Org: User:
Start: 03/31/18 End: 07/31/18 Due: 07/31/19

The Lamina Cribrosa (LC) Changes in the Eyes After Laser-Assisted in Situ Keratomileusis (LASIK)

Phase: N/A Priority: Normal
NCT ID: NCT02676557 Org: User:
Start: 04/30/14 End: 03/31/15 Due: 03/31/16

Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01149122 Org: User:
Start: 01/31/09 End: 06/30/12 Due: 06/30/13

Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Thoracic Aortic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01401218 Org: User:
Start: 07/31/11 End: 09/30/12 Due: 09/30/13

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

Phase: N/A Priority: Normal
NCT ID: NCT03117036 Org: User:
Start: 03/01/17 End: 12/28/26 Due: 12/28/27

Prognostic Implication of Angiography-Derived IMR in STEMI Patients

Phase: N/A Priority: Normal
NCT ID: NCT04628377 Org: User:
Start: 05/26/03 End: 04/01/23 Due: 04/01/24

Liquid Biopsy Using Methylation Sequencing for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04253509 Org: User:
Start: 02/03/20 End: 01/31/22 Due: 01/31/23

Bortezomib/Dexamethasone Therapy in Patients With Relapsed and/or Refractory Cutaneous T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03487133 Org: User:
Start: 09/19/17 End: 09/30/20 Due: 09/30/21

The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01540201 Org: User:
Start: 02/29/12 End: 10/31/12 Due: 10/31/13

Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02450149 Org: User:
Start: 05/30/16 End: 08/09/16 Due: 08/09/17

Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04967417 Org: User:
Start: 05/26/22 End: 12/02/24 Due: 12/02/25

Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02080065 Org: User:
Start: 01/31/14 End: 06/30/15 Due: 06/30/16